Amphastar Pharmaceuticals AMPH
NASDAQ AMPH
$25.43 +0.08 (+0.32%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amphastar Pharmaceuticals (AMPH) Change in Accured Expenses (2013 - 2026)

Updated

Amphastar Pharmaceuticals (AMPH) recorded Change in Accured Expenses of $1.96 million in Q2 2026, compared with -$4.86 million a year earlier and down 79.6% from the prior quarter.

Analysis

Amphastar Pharmaceuticals (AMPH) Change in Accured Expenses (2013 - 2026) Analysis & Trends

On a TTM basis, Amphastar Pharmaceuticals' Change in Accured Expenses came in at -$5.74 million as of Jun 30, 2026; for FY2025, it was -$4.56 million.

  • Across earlier years, Change in Accured Expenses came in at $63.56 million in FY2024 (+380.2%), $13.24 million in FY2023, -$736,000 in FY2022 and $3.63 million in FY2021 (-81.9%).
  • Quarterly Change in Accured Expenses has ranged from -$42.64 million in Q4 2025 to $25.34 million in Q3 2025 over the past five years.
  • On a year-over-year basis, Change in Accured Expenses rose in two of the last four quarters, with growth averaging 35.4%.
  • Peak year-over-year performance for Change in Accured Expenses in the last five years was growth of 913.7% in Q2 2022, against a decline of 50.4% in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $9.6 million (Q1 2026), -$42.64 million (Q4 2025) and $25.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.20 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 338.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Amphastar Pharmaceuticals 1.08 Bn -62.90 Mn 93.47 Mn 1.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.96 Mn
Mar 31, 2026 9.60 Mn
Dec 31, 2025 -42.64 Mn
Sep 30, 2025 25.34 Mn
Jun 30, 2025 -4.86 Mn
Mar 31, 2025 17.61 Mn
Dec 31, 2024 2.11 Mn
Sep 30, 2024 24.65 Mn
Jun 30, 2024 13.73 Mn
Mar 31, 2024 23.08 Mn
Dec 31, 2023 -3.39 Mn
Sep 30, 2023 8.00 Mn
Jun 30, 2023 3.11 Mn
Mar 31, 2023 5.51 Mn
Dec 31, 2022 -13.58 Mn
Sep 30, 2022 -296,000.00
Jun 30, 2022 3.70 Mn
Mar 31, 2022 9.44 Mn
Dec 31, 2021 -1.08 Mn
Sep 30, 2021 -14.71 Mn
API Access

Amphastar Pharmaceuticals Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=AMPH&period=max&api_key=YOUR_API_KEY